Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.22.1
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Common Stock Options [Member]    
Antidilutive securities, shares 177,815 11,715
Common Stock Warrants [Member]    
Antidilutive securities, shares 37,083 187,339
Conversion of Convertible Notes with Accured Interest [Member]    
Antidilutive securities, shares 77,117  
Conversion of Series A Stock Inclusive of Cumulative Dividends [Member]    
Antidilutive securities, shares 108,480  
Conversion of Series B Preferred Stock Inclusive of Dividends [Member]    
Antidilutive securities, shares 265,555  
Conversion of Debentures [Member]    
Antidilutive securities, shares   5,469
Conversion of Redeemable Convertible Preferred Stock [Member]    
Antidilutive securities, shares   75,000
Conversion of Series B Preferred Stock [Member]    
Antidilutive securities, shares   390,625
Conversion of Series E-1 Preferred Stock [Member].    
Antidilutive securities, shares   212,500